Unexpected Severe Bocavirus Infections among Hospitalized Children during the COVID-19 Pandemic

Abstract

Objective Acute respiratory tract infections are one of the leading causes of morbidity and mortality in children. Although human bocavirus (HBoV) infections are not as common as other seasonal respiratory viruses, children who are infected with HBoV are more likely to suffer from a variety of respiratory conditions, including the common cold, acute otitis media, asthma exacerbations, bronchiolitis pneumonia, some of the affected children require pediatric intensive care unit stay. Here, we aimed to evaluate pediatric bocavirus (HBoV) cases presenting with severe respiratory tract symptoms during the coronavirus disease 2019 (COVID-19) pandemic.

Methods This retrospective study evaluated the medical records of children diagnosed with respiratory infections, followed up at the Faculty of Medicine, Eskisehir Osmangazi University between September 2021 and March 2022. In this study, patients with HBoV identified using nasopharyngeal polymerase chain reaction (PCR) were considered positive. Cases were analyzed retrospectively for their clinical characteristics.

Results This study included 54 children (29 girls and 25 boys) with HBoV in nasopharyngeal PCR samples. The cases ranged in age from 1 month to 72 months (median 25 months). At the time of presentation, cough, fever, and respiratory distress were the most prevalent symptoms. Hyperinflation (48%), pneumonic consolidation (42%), and pneumothorax–pneumomediastinum (7%) were observed on the chest X-ray; 54% of the children required intensive care unit stay. The median length of hospitalization was 6 days. Bacterial coinfection was detected in 7 (17%) children, while HBoV and other viruses were present in 20 (37%) children; 57% of children received supplemental oxygen by mask, 24% high-flow nasal oxygen, 7% continuous positive airway pressure, and 9% invasive mechanical ventilation support. Antibiotics were given to 34 (63%) cases, and systemic steroid treatment was given to 41 (76%) cases. Chest tubes were inserted in three out of the four cases with pneumothorax–pneumomediastinum. All patients were recovered and were discharged from the hospital.

Conclusion The COVID-19 pandemic changed the epidemiology of seasonal respiratory viruses and the clinical course of the diseases. Although it usually causes mild symptoms, severe respiratory symptoms can lead to life-threatening illnesses requiring intensive care admission.

Keywords

children - COVID-19 pandemic - bocavirus

• References

• 1 Tang X, Dai G, Jiang X. et al. Clinical characteristics of pediatric respiratory tract infection and respiratory pathogen isolation during the coronavirus disease 2019 pandemic. Front Pediatr 2022; 9: 759213
• 2 Kahn J. Human bocavirus: clinical significance and implications. Curr Opin Pediatr 2008; 20 (01) 62-66
• 3 Principi N, Piralla A, Zampiero A. et al. Bocavirus infection in otherwise healthy children with respiratory disease. PLoS One 2015; 10 (08) e0135640
• 4 Moesker FM, van Kampen JJ, van der Eijk AA. et al. Human bocavirus infection as a cause of severe acute respiratory tract infection in children. Clin Microbiol Infect 2015; 21 (10) 964.e1-964.e8
• 5 Körner RW, Söderlund-Venermo M, van Koningsbruggen-Rietschel S, Kaiser R, Malecki M, Schildgen O. Severe human bocavirus infection, Germany. Emerg Infect Dis 2011; 17 (12) 2303-2305
• 6 Zhou L, Zheng S, Xiao Q. et al. Single detection of human bocavirus 1 with a high viral load in severe respiratory tract infections in previously healthy children. BMC Infect Dis 2014; 14: 424
• 7 Guido M, Zizza A, Bredl S. et al; Seroepidemiology Group. Seroepidemiology of human bocavirus in Apulia, Italy. Clin Microbiol Infect 2012; 18 (04) E74-E76
• 8 Jiang W, Yin F, Zhou W, Yan Y, Ji W. Clinical significance of different virus load of human bocavirus in patients with lower respiratory tract infection. Sci Rep 2016; 6: 20246
• 9 Ghietto LM, Majul D, Ferreyra Soaje P. et al. Comorbidity and high viral load linked to clinical presentation of respiratory human bocavirus infection. Arch Virol 2015; 160 (01) 117-127
• 10 Harun A, Beyza E. Viral and atypical bacterial respiratory infections in a university teaching hospital. Jpn J Infect Dis 2019; 72 (05) 318-322
• 11 Christensen A, Kesti O, Elenius V. et al. Human bocaviruses and paediatric infections. Lancet Child Adolesc Health 2019; 3 (06) 418-426
• 12 Ferguson NM, Laydon D, Nedjati Gilani G. et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. 2020. Last Accessed March 3, 2022, at: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf
• 13 Toelen J, Ritz N, de Winter JP. Changes in pediatric infections during the COVID-19 pandemic: ‘a quarantrend for coronials’?. Eur J Pediatr 2021; 180 (06) 1965-1967
• 14 Woolbert M, Spalding C, Sinaii N, Decker BK, Palmore TN, Henderson DK. Sharp decline in rates of community respiratory viral detection among patients at the National Institutes of Health Clinical Center during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2023; 44 (01) 62-67
• 15 Yum S, Hong K, Sohn S, Kim J, Chun BC. Trends in viral respiratory infections during COVID-19 pandemic, South Korea. Emerg Infect Dis 2021; 27 (06) 1685-1688
• 16 Maison N, Peck A, Illi S. et al. The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections. Infection 2022; 50 (02) 519-524
• 17 Delestrain C, Danis K, Hau I. et al. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV. Pediatr Pulmonol 2021; 56 (12) 3669-3673
• 18 Pappa S, Haidopoulou K, Zarras C. et al. Early initiation of the respiratory syncytial virus season in 2021-2022, Greece. J Med Virol 2022; 94 (07) 3453-3456
• 19 Deng X, Yan Z, Luo Y. et al. In vitro modeling of human bocavirus 1 infection of polarized primary human airway epithelia. J Virol 2013; 87 (07) 4097-4102
• 20 Fakhiri J, Linse KP, Mietzsch M. et al. Impact of natural or synthetic singletons in the capsid of human bocavirus 1 on particle infectivity and immunoreactivity. J Virol 2020; 94 (11) e00170-e20
• 21 Ivaska LE, Silvoniemi A, Palomares O. et al. Persistent human bocavirus 1 infection and tonsillar immune responses. Clin Transl Allergy 2021; 11 (06) e12030
• 22 Wang K, Wang W, Yan H. et al. Correlation between bocavirus infection and humoral response, and co-infection with other respiratory viruses in children with acute respiratory infection. J Clin Virol 2010; 47 (02) 148-155
• 23 Chow BD, Esper FP. The human bocaviruses: a review and discussion of their role in infection. Clin Lab Med 2009; 29 (04) 695-713
• 24 Kantola K, Hedman L, Arthur J. et al. Seroepidemiology of human bocaviruses 1-4. J Infect Dis 2011; 204 (09) 1403-1412
• 25 Hustedt JW, Christie C, Hustedt MM, Esposito D, Vazquez M. Seroepidemiology of human bocavirus infection in Jamaica. PLoS One 2012; 7 (05) e38206
• 26 Carman KB, Calik M, Karal Y. et al. Viral etiological causes of febrile seizures for respiratory pathogens (EFES Study). Hum Vaccin Immunother 2019; 15 (02) 496-502
• 27 Akturk H, Sık G, Salman N. et al. Atypical presentation of human bocavirus: severe respiratory tract infection complicated with encephalopathy. J Med Virol 2015; 87 (11) 1831-1838
• 28 Völz S, Schildgen O, Klinkenberg D. et al. Prospective study of human bocavirus (HBoV) infection in a pediatric university hospital in Germany 2005/2006. J Clin Virol 2007; 40 (03) 229-235
• 29 Broccolo F, Falcone V, Esposito S, Toniolo A. Human bocaviruses: possible etiologic role in respiratory infection. J Clin Virol 2015; 72: 75-81